Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Tongue Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Paranasal Sinus Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1

Interventions

Cisplatin 6Radiotherapy 5Fluorouracil 3Docetaxel 3Platinum 2Hydroxyurea 2Drug Therapy 2Celecoxib 2Carboplatin 21,2-diaminocyclohexaneplatinum II citrate 2toripalimab 1dehydroftorafur 1camrelizumab 1antineoplaston AS 2-1 1antineoplaston A10 1X-Rays 1Transurethral Resection of Bladder 1Therapeutics 1Specimen Handling 1Referral and Consultation 1Radiotherapy, Intensity-Modulated 1Radiation 1Observation 1Magnetic Resonance Spectroscopy 1Eucalyptus Oil 1Etoposide 1Erlotinib Hydrochloride 1Endoscopy 1Endoscopic Mucosal Resection 1Coal Tar 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Paranasal Sinus Neoplasms × Chemoprevention × Clear all
NCT01469429 2020-02-20

Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.

Ohio State University Comprehensive Cancer Center

Phase 1/2 Completed
70 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡